I call the meeting back to order.
I'd like to welcome our second panel of witnesses. We have with us this evening the Honourable Ya'ara Saks, Minister of Mental Health and Addictions. With her, representing the Canadian Institutes of Health Research, is Dr. Samuel Weiss, scientific director, Institute of Neurosciences, Mental Health and Addiction. Dr. Weiss is with us by video conference.
For the Department of Health, Eric Costen, acting deputy minister, is still here. We also have Michelle Boudreau, associate assistant deputy minister, health policy branch; and Jennifer Saxe, associate assistant deputy minister, controlled substances and cannabis branch.
Also in the room, representing the Public Health Agency of Canada, are Nancy Hamzawi, executive vice-president, and Michael Collins, vice-president, health promotion and chronic disease prevention branch. Thank you for your patience. Thank you for being with us.
Welcome to the committee, Minister Saks. You have five minutes for your opening statement.